Summary
A case of unresectable hepatocellular carcinoma which responded favorably to combined therapy with tumor necrosis factor (TNF) and local hyperthermia is reported. A 58-year-old man was admitted to our hospital in June 1988 for treatment of hepatocellular carcinoma affecting S4 and S8. After three sessions of transcatheter arterial embolization (TAE) therapy, the serum α1 fetoprotein level decreased, and a reduction in the size of the lesions was also noted. Thereafter, the patient received local hyperthermia once a week (60 minutes of irradiation from a Thermotron-RF8 at l,100W), but the α1-fetoprotein level increased again in February 1989. On examination, enlargement of the S8 lesion and a new nodule in S7 were recognized. Since TAE was contraindicated due to liver dysfunction, human recombinant TNF (1 × 106U) was given by intravenous infusion together with local hyperthermia once a week. Eight sessions of the combined therapy reduced the serum α1-fetoprotein level markedly (7,512.0 to 2,782.0pg/ml) and after eighteen sessions, 58.1% regression of tumor size (partial response) on computed tomography scans was observed. This anecdotal case supports previous experimental evidence suggesting that TNF plus hyperthermia may be effective for treating unresectable hepatocellular carcinoma.
Similar content being viewed by others
References
Yamada R, Sato M, Kawabata M, et al: Hepatic artery embolization in 120 patients with unresectable hepatoma. Radiology 1983;148: 397–401
Hiraoka M, Jo S, Akuta K, et al: Radiofrequency capacitive hyperthermia for deep-seated tumors: II. Effects of thermoradiology. Cancer 1987;60:128–135
Nagata Y, Hiraoka M, Akuta K, et al: Radiofrequency thermotherapy for malignant liver tumors. Cancer 1990;65:1730–1736
Ishikawa T, Imawari M, Moriyama T, et al: Immunotherapy of hepatocellular carcinoma with autologous lymphokine-activated killer cells and/or recombinant interleukin-2. J Cancer Res Clin Oncol 1988;114:283–290
Kimura K, Taguchi T, Urushizaki I, et al: Phase 1 study of recombinant human tumor necrosis factor. Cancer Chemother Pharmacol 1987;20:223–229
Watanabe N, Niitsu Y, Umeno H, et al: Synergistic cytotoxic and antitumor effects of recombinant human tumor necrosis factor and hyperthermia. Cancer Res 1988;48:650–653
Niitsu Y, Watanabe N, Umeno H, et al: Synergistic effects of recombinant human tumor necrosis factor and hyperthermia on in vitro cytotoxicity and artificial metastasis. Cancer Res 1988;48:654–657
Shirai T, Yamaguchi H, Ito H, et al: Cloning and expression in Escherichia coli of the gene for human tumor necrosis factor. Nature (Lond.) 1985;313:803–806
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Maeda, M., Watanabe, N., Yamauchi, N. et al. Successful treatment of a case of hepatocellular carcinoma with tumor necrosis factor and local hyperthermia. Gastroenterol Jpn 26, 774–778 (1991). https://doi.org/10.1007/BF02782867
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02782867